Resources
Click here for ASCO 2019 Insights
Immediately after the American Society of Clinical Oncology’s (ASCO) annual meeting ended on June 5, InCrowd launched a MicroSurvey to a large sample of oncologists and hematologists who attended to determine which data and developments were of greatest interest.
Download our survey report on what we learned within 24 hours of the conference.
Prescriber Perspectives on Weight Loss Drugs in 2023 Examine how healthcare professionals (HCPs) view and prescribe weight loss drugs currently on the market in our new Instant Insights report. Fielded in a single day, this report includes responses from 100 qualified...
Physician Perspectives on the 2023 ASCO Annual Meeting Curious what doctors thought about ASCO? Nearly 100 oncologists and hematologist oncologists shared with us the findings and developments they were most excited about. Check-out our 2023 Post-ASCO report to...
Adoption of Newly-Approved 1L mNSCLC Regimens Driven by Promotional Activities Promotion plays a major role in the successful launch of a new pharmaceutical product. Companies must develop a marketing strategy that effectively communicates the benefits of the therapy...